Contact a Lawyer Now
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 2, 2021 to file lead plaintiff applications in a securities class action lawsuit against Boston Scientific Corporation (NYSE: BSX).
Boston Scientific and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On November 17, 2020, the Company announced a global recall of all unused inventory of its LOTUS Edge Aortic Valve System, due to “complexities associated with the product delivery system,” and that “[g]iven the additional time and investment required to develop and reintroduce an enhanced delivery system, the company has chosen to retire the entire LOTUS product platform immediately.”
On this news, the price of Boston Scientific’s shares fell $3.00 per share, or 7.89%, to close at $35.03 per share on November 17, 2020.
If you purchased securities of Boston Scientific and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (firstname.lastname@example.org), or fill out the form on this page.
The case is Jevons v. Boston Scientific Corporation et al., 20-cv-5894.
Click here to read the case complaint.